193 related articles for article (PubMed ID: 36894968)
21. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.
Lister JJ; Brown S; Greenwald MK; Ledgerwood DM
Subst Abus; 2019; 40(2):185-193. PubMed ID: 30888262
[No Abstract] [Full Text] [Related]
22. Treatment provider perceptions of take-home methadone regulation before and during COVID-19.
Madden EF; Christian BT; Lagisetty PA; Ray BR; Sulzer SH
Drug Alcohol Depend; 2021 Nov; 228():109100. PubMed ID: 34600251
[TBL] [Abstract][Full Text] [Related]
23. Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: A narrative review.
Panwala V; Joudrey P; Kowalski M; Bach P; Amram O
J Subst Use Addict Treat; 2023 Sep; 152():209086. PubMed ID: 37270103
[TBL] [Abstract][Full Text] [Related]
24. The impact of COVID-19 on opioid treatment programs in the United States.
Goldsamt LA; Rosenblum A; Appel P; Paris P; Nazia N
Drug Alcohol Depend; 2021 Nov; 228():109049. PubMed ID: 34600258
[TBL] [Abstract][Full Text] [Related]
25. Preferences for methadone clinics among drug users in Vietnam: a comparison between public and private models.
Le TA; Nguyen TA; Dang AD; Nguyen CT; Phan HT; Vu GT; Nguyen THT; Latkin CA; Ho CSH; Ho RCM; Tran BX; Ying J; Zhang MWB
Harm Reduct J; 2020 Jan; 17(1):1. PubMed ID: 31906957
[TBL] [Abstract][Full Text] [Related]
26. Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff.
Mitchell SG; Jester J; Gryczynski J; Whitter M; Fuller D; Halsted C; Schwartz RP
Addict Sci Clin Pract; 2023 Oct; 18(1):61. PubMed ID: 37848970
[TBL] [Abstract][Full Text] [Related]
27. Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs.
Krawczyk N; Maniates H; Hulsey E; Smith JS; DiDomenico E; Stuart EA; Saloner B; Bandara S
J Addict Med; 2022 Nov-Dec 01; 16(6):645-652. PubMed ID: 35165225
[TBL] [Abstract][Full Text] [Related]
28. Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis.
Kitchen SA; Campbell TJ; Men S; Bozinoff N; Tadrous M; Antoniou T; Wyman J; Werb D; Munro C; Gomes T
Int J Drug Policy; 2022 May; 103():103644. PubMed ID: 35272107
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of an implementation of methadone maintenance treatment in China.
Marienfeld C; Liu P; Wang X; Schottenfeld R; Zhou W; Chawarski MC
Drug Alcohol Depend; 2015 Dec; 157():60-7. PubMed ID: 26601934
[TBL] [Abstract][Full Text] [Related]
30. Changes in methadone take-home dosing before and after COVID-19.
Amram O; Amiri S; Thorn EL; Lutz R; Joudrey PJ
J Subst Abuse Treat; 2022 Feb; 133():108552. PubMed ID: 34304950
[TBL] [Abstract][Full Text] [Related]
31. Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction).
Suen LW; Incze M; Simon C; Englander H; Bratberg J; Groves Scott G; Winograd R
Subst Use Addctn J; 2024 Jul; 45(3):337-345. PubMed ID: 38804606
[TBL] [Abstract][Full Text] [Related]
32. Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore.
Abidogun TM; Cole TO; Massey E; Kleinman M; Greenblatt AD; Seitz-Brown CJ; Magidson JF; Belcher AM
J Subst Use Addict Treat; 2023 Feb; 145():208946. PubMed ID: 36880915
[TBL] [Abstract][Full Text] [Related]
33. Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi'an, China.
Zhou K; Li H; Wei X; Li X; Zhuang G
J Addict Med; 2017; 11(1):28-33. PubMed ID: 27649264
[TBL] [Abstract][Full Text] [Related]
34. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
[TBL] [Abstract][Full Text] [Related]
35. Effect of community-based extension clinics of methadone maintenance therapy for opiate-dependent clients: A prospective cohort study in Dehong Prefecture, Yunnan Province of China.
Zhang G; Yang Y; Ye R; Zhang D; Shan D; Hu Y; Dai B; Liu Z
Medicine (Baltimore); 2018 Nov; 97(47):e13323. PubMed ID: 30461647
[TBL] [Abstract][Full Text] [Related]
36. Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year.
Bart G; Wastvedt S; Hodges JS; Rosenthal R
J Subst Abuse Treat; 2022 Feb; 133():108590. PubMed ID: 34373169
[TBL] [Abstract][Full Text] [Related]
37. A chance to do it better: Methadone maintenance treatment in the age of Covid-19.
Frank D
J Subst Abuse Treat; 2021 Apr; 123():108246. PubMed ID: 33612189
[TBL] [Abstract][Full Text] [Related]
38. "Sign Me Up": a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic.
Darnton JB; Bhatraju EP; Beima-Sofie K; Michaels A; Hallgren KA; Soth S; Grekin P; Woolworth S; Tsui JI
Addict Sci Clin Pract; 2023 Mar; 18(1):21. PubMed ID: 36991506
[TBL] [Abstract][Full Text] [Related]
39. The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study.
Livingston NA; Davenport M; Head M; Henke R; LeBeau LS; Gibson TB; Banducci AN; Sarpong A; Jayanthi S; Roth C; Camacho-Cook J; Meng F; Hyde J; Mulvaney-Day N; White M; Chen DC; Stein MD; Weisberg R
Drug Alcohol Depend; 2022 Dec; 241():109678. PubMed ID: 36368167
[TBL] [Abstract][Full Text] [Related]
40. Characterizing Self-Reports of Self-Identified Patient Experiences with Methadone Maintenance Treatment on an Online Community during COVID-19.
Nobles AL; Johnson DC; Leas EC; Goodman-Meza D; Zúñiga ML; Ziedonis D; Strathdee SA; Ayers JW
Subst Use Misuse; 2021; 56(14):2134-2140. PubMed ID: 34486471
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
